Clinical trials
Completed Phase 2 Hemoglobinopathies trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Case Western Reserve University | 1 |
| Children's Hospital of Philadelphia | 1 |
| Dana-Farber Cancer Institute | 1 |
| Forma Therapeutics, Inc. | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Hillhurst Biopharmaceuticals, Inc. | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| Novartis Pharmaceuticals | 1 |
| medac GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemoglobinopathies | 11 |
| Anemia, Sickle Cell | 6 |
| Hematologic Diseases | 5 |
| Thalassemia | 5 |
| beta-Thalassemia | 4 |
| Anemia | 3 |
| Anemia, Hemolytic | 2 |
| Bone Marrow Failure Disorders | 2 |
| Genetic Diseases, Inborn | 2 |
| Iron Overload | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.